MCM
GILD icon

Matarin Capital Management’s Gilead Sciences GILD Stock Holding History

Matarin Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-49,974
Closed -$4.17M – 239
2016
Q2 		$4.17M Buy
49,974
+5,030
+11% +$446K 0.57% 75
2016
Q1 		$4.13M Buy
44,944
+3,895
+9% +$351K 0.58% 74
2015
Q4 		$4.15M Buy
41,049
+29,477
+255% +$3.07M 0.62% 74
2015
Q3 		$1.14M Sell
11,572
-6,661
-37% -$740K 0.23% 129
2015
Q2 		$2.13M Hold
18,233
– – 0.61% 71
2015
Q1 		$1.79M Buy
18,233
+3,356
+23% +$341K 0.54% 93
2014
Q4 		$1.4M Buy
14,877
+458
+3% +$47.4K 0.62% 80
2014
Q3 		$1.53M Sell
14,419
-652
-4% -$63.8K 0.7% 71
2014
Q2 		$1.25M Buy
15,071
+6,130
+69% +$477K 0.56% 82
2014
Q1 		$634K Buy
+8,941
New +$701K 0.37% 101
2013
Q4 		– Sell
-10,199
Closed -$641K – 135
2013
Q3 		$641K Sell
10,199
-1,213
-11% -$72.5K 0.54% 77
2013
Q2 		$585K Buy
+11,412
New +$595K 0.59% 68

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Matarin Capital Management's GILD Position: Q3 2016 in Review

Matarin Capital Management sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 49,974 shares — an estimated $4.17M sold.

Matarin Capital Management first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $4.17M in Q2 2016. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Matarin Capital Management reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Matarin Capital Management sold 49,974 Gilead Sciences shares in Q3 2016, an estimated $4.17M.
  • Matarin Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • Matarin Capital Management's Gilead Sciences position peaked at $4.17M in Q2 2016.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Matarin Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.